Section Arrow
Quote
RGEN.NASDAQ
- Repligen Corp
Quotes are at least 15-min delayed:2026/02/16 16:23 EST
Regular Hours
Last
 136.44
+3.81 (+2.87%)
Day High 
140.75 
Prev. Close
132.63 
1-M High
174.87 
Volume 
767.02K 
Bid
120
Ask
160
Day Low
133.3901 
Open
133.97 
1-M Low
130.4 
Market Cap 
7.47B 
Currency 美元 
P/E 6,631.5 
%Yield -- 
10-SMA 143.73 
20-SMA 153.4 
50-SMA 159.93 
52-W High 175.77 
52-W Low 102.965 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.02/2.51
Enterprise Value
8.14B
Balance Sheet
Book Value Per Share
37.01
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
29.36M
Operating Revenue Per Share
11.90
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BAXBaxter International19.79+1.08+5.77%-- 
AVTRAvantor9.2+0.06+0.66%-- 
XRAYDENTSPLY SIRONA12.95+0.14+1.09%-- 
MBOTMicrobot Medical2.17+0.08+3.83%-- 
BDXBecton Dickinson and Co175.89-1.92-1.08%29.05PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.